Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.

Abstract:

:Loss or mutation of the TP53 tumor suppressor gene is not commonly observed in acute myeloid leukemia (AML), suggesting that there is an alternate route for cell transformation. We investigated the hypothesis that previously observed Bcl-2 family member overexpression suppresses wild-type p53 activity in AML. We demonstrate that wild-type p53 protein is expressed in primary leukemic blasts from patients with de novo AML using 2-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and phospho-specific flow cytometry. We found that p53 was heterogeneously expressed and phosphorylated in AML patient samples and could accumulate following DNA damage. Overexpression of antiapoptosis protein Bcl-2 in AML cells was directly correlated with p53 expression and phosphorylation on serine residues 15, 46, and 392. Within those patients with the highest levels of Bcl-2 expression, we identified a mutation in FLT3 that duplicated phosphorylation site Y591. The presence of this mutation correlated with greater than normal Bcl-2 expression and with previously observed profiles of potentiated STAT and MAPK signaling. These results support the hypothesis that Flt3-mediated signaling in AML enables accumulation of Bcl-2 and maintains a downstream block to p53 pathway apoptosis. Bcl-2 inhibition might therefore improve the efficacy of existing AML therapies by inactivating this suppression of wild-type p53 activity.

journal_name

Blood

journal_title

Blood

authors

Irish JM,Anensen N,Hovland R,Skavland J,Børresen-Dale AL,Bruserud O,Nolan GP,Gjertsen BT

doi

10.1182/blood-2006-02-004234

subject

Has Abstract

pub_date

2007-03-15 00:00:00

pages

2589-96

issue

6

eissn

0006-4971

issn

1528-0020

pii

blood-2006-02-004234

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

    abstract::Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4) bound to heparin. Immunogenicity of heparins differs in that unfractionated heparin (UFH) induces more anti-PF4/heparin antibodies than low-molecular-weight heparin (LMWH) and UFH also causes m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2005-05-1938

    authors: Warkentin TE,Cook RJ,Marder VJ,Sheppard JA,Moore JC,Eriksson BI,Greinacher A,Kelton JG

    更新日期:2005-12-01 00:00:00

  • Response to hypoxia involves transforming growth factor-beta2 and Smad proteins in human endothelial cells.

    abstract::Oxygen deprivation (hypoxia) is a consistent component of ischemia that induces an inflammatory and prothrombotic response in the endothelium. In this report, it is demonstrated that exposure of endothelial cells to hypoxia (1% O(2)) increases messenger RNA and protein levels of transforming growth factor-beta2 (TGF-b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.12.3324

    authors: Akman HO,Zhang H,Siddiqui MA,Solomon W,Smith EL,Batuman OA

    更新日期:2001-12-01 00:00:00

  • Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma.

    abstract::Chromosomal rearrangements affecting RUNX1 and CBFB are common in acute leukemias. These mutations result in the expression of fusion proteins that act dominant-negatively to suppress the normal function of the Runt-related transcription factor 1 (RUNX)/core binding factor beta (CBFbeta) complexes. In addition, loss-o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-04-1447

    authors: Kundu M,Compton S,Garrett-Beal L,Stacy T,Starost MF,Eckhaus M,Speck NA,Liu PP

    更新日期:2005-11-15 00:00:00

  • Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family.

    abstract::The study of the molecular bases of thrombophilia in a large family with 4 symptomatic members is reported. Three thrombophilic genetic components (FV R506Q, FV H1299R, and PT 20210G/A), all affecting the activity of the prothrombinase complex, were detected alone and in combination in various family members. In addit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Castoldi E,Simioni P,Kalafatis M,Lunghi B,Tormene D,Girelli D,Girolami A,Bernardi F

    更新日期:2000-08-15 00:00:00

  • alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism.

    abstract::The Aalpha-fibrinogen Thr312Ala polymorphism, which occurs in a region involved in factor XIII (FXIII)-dependent cross-linking processes, is associated with poststroke mortality in subjects with atrial fibrillation, suggesting an influence either on intraatrial clot formation or embolization. We have determined the as...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carter AM,Catto AJ,Kohler HP,Ariëns RA,Stickland MH,Grant PJ

    更新日期:2000-08-01 00:00:00

  • Enrichment and functional characterization of Sca-1+WGA+, Lin-WGA+, Lin-Sca-1+, and Lin-Sca-1+WGA+ bone marrow cells from mice with an Ly-6a haplotype.

    abstract::Approximately 4% to 5% of all bone marrow (BM) cells and 8% to 9% of low density BM cells from FVB/N and BALB/c mice (Ly-6a haplotype) show high to intermediate expression of Ly-6E.1 antigen, recognized by the Sca-1 antibody. Functional properties of enriched cells expressing Ly-6E.1-allelic form of Sca-1 antigen were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jurecic R,Van NT,Belmont JW

    更新日期:1993-11-01 00:00:00

  • The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF.

    abstract::While studying patient plasma containing an unusual pattern of von Willebrand factor (VWF) multimers, we discovered a previously unreported phenomenon: heavy predominance of dimeric VWF. Genomic analysis revealed a new congenital mutation (Tyr87Ser) that altered the final stages of VWF biosynthesis. This mutation in t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0789

    authors: Rosenberg JB,Haberichter SL,Jozwiak MA,Vokac EA,Kroner PA,Fahs SA,Kawai Y,Montgomery RR

    更新日期:2002-09-01 00:00:00

  • Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.

    abstract::A 64-yr-old female developed acute myeloblastic leukemia following radiation and drug therapy for colon carcinoma. The patient was heterozygous for glucose-6-phosphate dehydrogenase (G-6-PD) and displayed types A and B isoenzymes in nonhematopoietic tissue. In contrast, only type B G-6-PD was observed in peripheral bl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wiggans RG,Jacobson RJ,Fialkow PJ,Woolley PV 3rd,Macdonald JS,Schein PS

    更新日期:1978-10-01 00:00:00

  • Functional cell surface expression of band 3, the human red blood cell anion exchange protein (AE1), in K562 erythroleukemia cells: band 3 enhances the cell surface reactivity of Rh antigens.

    abstract::Human K562 erythroleukemia cells were transfected with human band 3 (anion exchanger 1 [AE1]) cDNA, using the pBabe retroviral vector. Stable K562 clones expressing band 3 were isolated by flow cytometry, and surface expression was quantified by immunoblotting. The function of band 3 expressed at the cell surface was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Beckmann R,Smythe JS,Anstee DJ,Tanner MJ

    更新日期:1998-12-01 00:00:00

  • Stromal cells retard the differentiation of CD34(+)CD38(low/neg) human primitive progenitors exposed to cytokines independent of their mitotic history.

    abstract::Stem cell proliferation induced by potent cytokines usually leads to a loss of primitive potential through differentiation. In this study, the ability of cytokines and murine MS5 stromal cells to independently regulate the proliferation and long-term culture-initiating cell (LTC-IC) activity of primitive CD34(+)CD38(l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.2.435

    authors: Bennaceur-Griscelli A,Pondarré C,Schiavon V,Vainchenker W,Coulombel L

    更新日期:2001-01-15 00:00:00

  • MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival.

    abstract::The molecular mechanisms that underlie T-cell quiescence are poorly understood. In the present study, we report a primary immunodeficiency phenotype associated with MST1 deficiency and primarily characterized by a progressive loss of naive T cells. The in vivo consequences include recurrent bacterial and viral infecti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-378364

    authors: Nehme NT,Schmid JP,Debeurme F,André-Schmutz I,Lim A,Nitschke P,Rieux-Laucat F,Lutz P,Picard C,Mahlaoui N,Fischer A,de Saint Basile G

    更新日期:2012-04-12 00:00:00

  • Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase.

    abstract::Interleukin 2 (IL-2) rescued human natural killer (NK) KHYG-1 cells from apoptosis along with a reduction of ceramide. Conversely, an increase of ceramide inhibited IL-2-rescued survival. IL-2 deprivation-induced activation of acid sphingomyelinase (SMase) and inhibition of glucosylceramide synthase (GCS) and sphingom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-0900

    authors: Taguchi Y,Kondo T,Watanabe M,Miyaji M,Umehara H,Kozutsumi Y,Okazaki T

    更新日期:2004-11-15 00:00:00

  • Long-term suspension cultures of human cord blood myeloid cells.

    abstract::A method is described that allows for the routine long-term (greater than 3 mo) growth of normal, immature human myeloid cells in liquid suspension culture. The techniques employ cell separation, utilization of special growth conditions (RPMI with hydrocortisone and vitamin D), and cord blood as the source of leukocyt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Salahuddin SZ,Markham PD,Ruscetti FW,Gallo RC

    更新日期:1981-11-01 00:00:00

  • Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

    abstract::To assess the relationship between venous thrombosis and plasma glucosylceramide (GlcCer) or phosphatidylethanolamine (PE), plasma levels of GlcCer and PE were determined for 70 venous thrombosis patients referred for evaluation and 70 healthy blood donors. The mean GlcCer level, but not the PE level, was lower in pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.7.1907

    authors: Deguchi H,Fernández JA,Pabinger I,Heit JA,Griffin JH

    更新日期:2001-04-01 00:00:00

  • Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.

    abstract::MEIS1 is a three-amino acid loop extension class homeodomain-containing homeobox (HOX) cofactor that plays key roles in normal hematopoiesis and leukemogenesis. Expression of Meis1 is rate-limiting in MLL-associated leukemias and potently interacts with Hox and NUP98-HOX genes in leukemic transformation to promote sel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-06-225573

    authors: Argiropoulos B,Yung E,Xiang P,Lo CY,Kuchenbauer F,Palmqvist L,Reindl C,Heuser M,Sekulovic S,Rosten P,Muranyi A,Goh SL,Featherstone M,Humphries RK

    更新日期:2010-05-20 00:00:00

  • V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events.

    abstract::IgM-secreting plasma cell tumors are rare variants of typical isotype-switched multiple myeloma with a similar disease outcome. To probe the origin and clonal history of these tumors, we have analyzed V(H) gene sequences in 6 cases. Potentially functional tumor-derived V(H) genes were all derived from V(H)3, with the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sahota SS,Garand R,Mahroof R,Smith A,Juge-Morineau N,Stevenson FK,Bataille R

    更新日期:1999-08-01 00:00:00

  • CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.

    abstract::Human natural killer (NK) cells comprise 2 main subsets, CD56(bright) and CD56(dim) cells, that differ in function, phenotype, and tissue localization. To further dissect the heterogeneity of CD56(dim) cells, we have performed transcriptome analysis and functional ex vivo characterization of human NK-cell subsets acco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-253286

    authors: Juelke K,Killig M,Luetke-Eversloh M,Parente E,Gruen J,Morandi B,Ferlazzo G,Thiel A,Schmitt-Knosalla I,Romagnani C

    更新日期:2010-08-26 00:00:00

  • Phase 2 study of subcutaneous omacetaxine mepesuccinate after TKI failure in patients with chronic-phase CML with T315I mutation.

    abstract::Chronic myeloid leukemia (CML) patients with the BCR-ABL T315I mutation do not benefit from therapy with currently approved tyrosine kinase inhibitors. Omacetaxine mepesuccinate is a protein synthesis inhibitor that has demonstrated activity in cells harboring the T315I mutation. This phase 2 trial assessed the effica...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2012-03-415307

    authors: Cortes J,Lipton JH,Rea D,Digumarti R,Chuah C,Nanda N,Benichou AC,Craig AR,Michallet M,Nicolini FE,Kantarjian H,Omacetaxine 202 Study Group.

    更新日期:2012-09-27 00:00:00

  • T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage.

    abstract::The family of core-binding factors includes the DNA-binding subunits Runx1-3 and their common non-DNA-binding partner CBFbeta. We examined the collective role of core-binding factors in hematopoiesis with a hypomorphic Cbfb allelic series. Reducing CBFbeta levels by 3- or 6-fold caused abnormalities in bone developmen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021188

    authors: Talebian L,Li Z,Guo Y,Gaudet J,Speck ME,Sugiyama D,Kaur P,Pear WS,Maillard I,Speck NA

    更新日期:2007-01-01 00:00:00

  • Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma.

    abstract::Understanding the molecular pathogenesis of lymphoma has led to paradigm-changing treatment opportunities. One example involves tailoring specific agents based on the cell of origin in aggressive lymphomas. Germinal center (GC)-derived diffuse large B-cell lymphoma (DLBCL) is known to be driven by an addiction to Bcl6...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-485441

    authors: Amengual JE,Clark-Garvey S,Kalac M,Scotto L,Marchi E,Neylon E,Johannet P,Wei Y,Zain J,O'Connor OA

    更新日期:2013-09-19 00:00:00

  • STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.

    abstract::The tumorigenicity of most cases of ALK-positive anaplastic large-cell lymphoma (ALK+ ALCL) is driven by the oncogenic fusion protein NPM-ALK in a STAT3-dependent manner. Because it has been shown that STAT3 can be inhibited by STAT1 in some experimental models, we hypothesized that the STAT1 signaling pathway is defe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-10-603738

    authors: Wu C,Molavi O,Zhang H,Gupta N,Alshareef A,Bone KM,Gopal K,Wu F,Lewis JT,Douglas DN,Kneteman NM,Lai R

    更新日期:2015-07-16 00:00:00

  • Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

    abstract::The stage of progenitor maturation and factors that determine the fate and clonal acquisition of human natural killer (NK) cell receptors during development are unknown. To study human NK cell receptor ontogeny, umbilical cord blood CD34(+)/Lin(-)/CD38(-) cells were cultured with a murine fetal liver line (AFT024) and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.705

    authors: Miller JS,McCullar V

    更新日期:2001-08-01 00:00:00

  • Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony-stimulating factor to humans.

    abstract::Administration of hematopoietic growth factors is being used increasingly to obtain populations of blood progenitor/stem cells (PBPC) for clinical transplantation. Here we examined the effect of combining stem cell factor (SCF ) and granulocyte colony-stimulating factor (G-CSF ) versus G-CSF alone in a randomized clin...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Begley CG,Basser R,Mansfield R,Thomson B,Parker WR,Layton J,To B,Cebon J,Sheridan WP,Fox RM,Green MD

    更新日期:1997-11-01 00:00:00

  • Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.

    abstract::Erdheim-Chester disease (ECD) pathophysiology remains largely unknown. Its treatment is not codified and usually disappointing. Interferon (IFN)-α therapy lacks efficacy for some life-threatening manifestations and has a poor tolerance profile. Because interleukin (IL)-1Ra synthesis is naturally induced after stimulat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279240

    authors: Aouba A,Georgin-Lavialle S,Pagnoux C,Martin Silva N,Renand A,Galateau-Salle F,Le Toquin S,Bensadoun H,Larousserie F,Silvera S,Provost N,Candon S,Seror R,de Menthon M,Hermine O,Guillevin L,Bienvenu B

    更新日期:2010-11-18 00:00:00

  • Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

    abstract::Concurrent activation of the T-cell receptor (TCR) and complement regulator CD46 on human CD4+ T lymphocytes induces Tr1-like regulatory T cells that suppress through IL-10 secretion bystander T-cell proliferation. Here we show that, despite their IL-10 production, CD46-induced T-regulatory T cells (Tregs) do not supp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-2951

    authors: Barchet W,Price JD,Cella M,Colonna M,MacMillan SK,Cobb JP,Thompson PA,Murphy KM,Atkinson JP,Kemper C

    更新日期:2006-02-15 00:00:00

  • The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.

    abstract::Global gene expression profiling of highly purified 5q-deleted CD34+CD38(-)Thy1+ cells in 5q- myelodysplastic syndromes (MDSs) supported that they might originate from and outcompete normal CD34+CD38(-)Thy1+ hematopoietic stem cells. Few but distinct differences in gene expression distinguished MDS and normal stem cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-079368

    authors: Nilsson L,Edén P,Olsson E,Månsson R,Astrand-Grundström I,Strömbeck B,Theilgaard-Mönch K,Anderson K,Hast R,Hellström-Lindberg E,Samuelsson J,Bergh G,Nerlov C,Johansson B,Sigvardsson M,Borg A,Jacobsen SE

    更新日期:2007-10-15 00:00:00

  • Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.

    abstract::During mouse cytomegalovirus (CMV) infection, a population of Ly49H(+) natural killer (NK) cells expands and is responsible for disease clearance through the induction of a "memory NK-cell response." Whether similar events occur in human CMV infection is unknown. In the present study, we characterized the kinetics of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-386995

    authors: Foley B,Cooley S,Verneris MR,Pitt M,Curtsinger J,Luo X,Lopez-Vergès S,Lanier LL,Weisdorf D,Miller JS

    更新日期:2012-03-15 00:00:00

  • How I treat patients with indolent and smoldering mastocytosis (rare conditions but difficult to manage).

    abstract::Indolent systemic mastocytosis (SM) patients have a varied clinical presentation, ranging from predominantly cutaneous symptoms to recurrent systemic symptoms (eg, flushing, palpitations, dyspepsia, diarrhea, bone pain) that can be severe and potentially life threatening (anaphylaxis). Mastocytosis patients without sk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-453183

    authors: Pardanani A

    更新日期:2013-04-18 00:00:00

  • Varying intensity of postremission therapy in acute myeloid leukemia.

    abstract::The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would improve the outcome. After uniform induction therapy, patients in com...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Cassileth PA,Lynch E,Hines JD,Oken MM,Mazza JJ,Bennett JM,McGlave PB,Edelstein M,Harrington DP,O'Connell MJ

    更新日期:1992-04-15 00:00:00

  • Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

    abstract::The past 40 years have witnessed major advances in defining the cytogenetic aberrations, mutational landscape, epigenetic profiles, and expression changes underlying hematological malignancies. Although it has become apparent that acute myeloid leukemia (AML) is highly heterogeneous at the molecular level, the standar...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-05-577593

    authors: Grimwade D,Freeman SD

    更新日期:2014-11-27 00:00:00